Apparent diffusion coefficient and dynamic contrast-enhanced MRI as reliable biomarkers for evaluating response to locoregional therapy in hepatocellular carcinoma patients

ConclusionThe use of DW-MRI (with ADC data and colored maps) and the DCE-MRI (with digital subtraction and color-coded perfusion maps) can be considered as in-vivo digital biomarkers for evaluating the response to LRT in patients with HCC.
Source: The Egyptian Journal of Radiology and Nuclear Medicine - Category: Nuclear Medicine Source Type: research